These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29980453)

  • 21. Adherence to clinical guidelines in heart failure (HF) outpatients: Impact of an interprofessional HF team on evidence-based medication use.
    Crissinger ME; Marchionda KM; Dunlap ME
    J Interprof Care; 2015; 29(5):483-7. PubMed ID: 26091371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
    Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes.
    Lo KB; Toroghi HM; Salacup G; Jiang J; Bhargav R; Quintero E; Balestrini K; Shahzad A; Mathew RO; McCullough PA; Rangaswami J
    Rev Cardiovasc Med; 2021 Mar; 22(1):199-206. PubMed ID: 33792263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
    Hirai T; Yamaga R; Fujita A; Itoh T
    J Clin Pharm Ther; 2018 Dec; 43(6):829-835. PubMed ID: 29908131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF.
    Linssen GCM; Veenis JF; Kleberger A; Grosfeld MJW; Viergever EP; van Dalen BM; de Valk-Bedijn W; Langerveld J; Brunner-La Rocca HP; Hoes AW; Brugts JJ;
    Clin Res Cardiol; 2020 Sep; 109(9):1155-1164. PubMed ID: 32030498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
    Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
    Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a pharmacist-managed heart failure medication titration clinic.
    Martinez AS; Saef J; Paszczuk A; Bhatt-Chugani H
    Am J Health Syst Pharm; 2013 Jun; 70(12):1070-6. PubMed ID: 23719886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
    J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
    Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ
    Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
    Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
    Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.